Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethane SCHEMBL17237502 | 1.00 | TRPA1 (0.33) | TRPA1TRPM8 | |
| SCHEMBL1870837 | 0.98 | TRPA1 (0.34) | TRPA1TRPM8 | |
| Methane SCHEMBL3445491 | 0.96 | TRPA1 (0.33) | TRPA1TRPM8 | |
| Methane SCHEMBL5185768 | 0.96 | TRPA1 (0.33) | TRPA1TRPM8 | |
| SCHEMBL14515122 | 0.80 | TRPA1 (0.34) | TRPA1TRPM8 | |
| SCHEMBL4918912 | 0.78 | TRPA1 (0.33) | TRPA1TRPM8 | |
| SCHEMBL12671701 | 0.78 | TRPA1 (0.33) | TRPA1TRPM8 | |
| SCHEMBL11677336 | 0.78 | TRPA1 (0.33) | TRPA1TRPM8 | |
| SCHEMBL17244697 | 0.78 | TRPA1 (0.33) | TRPA1TRPM8 | |
| SCHEMBL7972506 | 0.77 | TRPA1 (0.32) | TRPA1TRPM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1791801-B1 | P-METHAN-(3)OL ALKYLATED DERIVATIVES AND USE THEREOF AS REFRESHING AGENTS | ROBERTET SA (FR) | 2015-11-11 | — | — | EP | claimed |
| US-7816566-B2 | p-Menthan-3-ol alkylated derivatives and their use as refreshing agents | ROBERTET S.A. (FR) | 2010-10-19 | — | — | US | claimed |
| US-20090163733-A1 | P-menthan-3-ol alkylated derivatives and their use as refreshing agents | ROBERTET S.A. (FR) | 2009-06-25 | — | — | US | claimed |
| EP-1791801-A1 | P-METHAN-(3)OL ALKYLATED DERIVATIVES AND USE THEREOF AS REFRESHING AGENTS | Robertet S.A. (FR) | 2007-06-06 | — | — | EP | claimed |
| WO-2005121058-A1 | P-MENTHAN-(3) OL ALKYLATED DERIVATIVES AND USE THEREOF AS REFRESHING AGENTS | ROBERTET S.A. (FR) | 2005-12-22 | — | — | WO | claimed |
| EP-1791801-B1 | P-METHAN-(3)OL ALKYLATED DERIVATIVES AND USE THEREOF AS REFRESHING AGENTS | ROBERTET SA (FR) | 2015-11-11 | — | — | EP | disclosed |
| US-7816566-B2 | p-Menthan-3-ol alkylated derivatives and their use as refreshing agents | ROBERTET S.A. (FR) | 2010-10-19 | — | — | US | disclosed |
| US-20090163733-A1 | P-menthan-3-ol alkylated derivatives and their use as refreshing agents | ROBERTET S.A. (FR) | 2009-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090163733-A1 | P-menthan-3-ol alkylated derivatives and their use as refreshing agents | MSMO1, EP300, HAAO | TRPA1 61/4885TRPM8 89/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.